ESR1 and breast cancer: As anti-estrogens, I3C and DIM are known to have anti-tumorigenic properties by targeting ER-alpha (ER-α), and DIM was more effective than I3C at depressing mRNA expression of ER-α in MCF-7 breast cancer cells [43].